Home » Prices » NASDAQ:LMNL

Liminal BioSciences Inc. NASDAQ:LMNL

Today's live share price, quote history, chart & news

Price:
18.38 USD
Change:
-0.22 (-1.18%)
Key Stats
Price open
Previous close 18.6
Market cap 428.49M
Volume 57.37K
Day high 18.79
Day low 17.172
Year high 31.45
Year low 7.33
Year to date change 127.05%
P/E Ratio -1.99
Company Profile
Fundamentals
Insider Information
News

About Liminal BioSciences Inc.

Liminal BioSciences, Inc. is a biopharmaceutical corporation. The firm engages in the development of therapeutic products focusing on unmet medical needs in the field of fibrosis, autoimmune disease or inflammation and cancer. It operates through the following segments: Small Molecule Therapeutics and Plasma-derived Therapeutics. The Small Molecule Therapeutics segment focuses on discovering, developing and commercializing novel treatments for patients suffering from diseases related to fibrosis, including conditions of the lung, liver and kidney. The Plasma-derived Therapeutics segment provides efficient extraction and purification of therapeutic proteins from human plasma. The company was founded on October 14, 1994 and is headquartered in Laval, Canada.

Company information

Company name
Liminal BioSciences, Inc.
Exchange
Sector
Health Technology
Industry
Biotechnology
Employees
300
CEO
Kenneth Harry Galbraith
Address
440 Armand-Frappier Boulevard, Laval, QC, H7V
Country
Canada
Contact information
1.450.781.0115
Website
http://www.liminalbiosciences.com
Invezz uses cookies to provide you with a great user experience. By using Invezz, you accept our privacy policy.